Literature DB >> 12079894

Anti-interleukin 1alpha autoantibodies.

P Miossec1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12079894      PMCID： PMC1754161          DOI： 10.1136/ard.61.7.577

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  27 in total

1.  Identification of high-affinity anti-IL-1 alpha autoantibodies in normal human serum as an interfering substance in a sensitive enzyme-linked immunosorbent assay for IL-1 alpha.

Authors:  N Mae; D J Liberato; R Chizzonite; H Satoh
Journal:  Lymphokine Cytokine Res       Date:  1991-04

2.  Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells.

Authors:  Shinobu Saijo; Masahide Asano; Reiko Horai; Hiroaki Yamamoto; Yoichiro Iwakura
Journal:  Arthritis Rheum       Date:  2002-02

3.  IgG autoantibodies against interleukin 1 alpha in sera of normal individuals.

Authors:  M Svenson; L K Poulsen; A Fomsgaard; K Bendtzen
Journal:  Scand J Immunol       Date:  1989-04       Impact factor: 3.487

4.  The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.

Authors:  M Chabaud; P Miossec
Journal:  Arthritis Rheum       Date:  2001-06

5.  IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

Authors:  L A Joosten; M M Helsen; T Saxne; F A van De Loo; D Heinegard; W B van Den Berg
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

6.  Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera.

Authors:  M Svenson; M Bagge Hansen; K Bendtzen
Journal:  Scand J Immunol       Date:  1990-12       Impact factor: 3.487

7.  Human anti-interleukin 1 alpha antibodies.

Authors:  M B Hansen; M Svenson; K Bendtzen
Journal:  Immunol Lett       Date:  1991-09       Impact factor: 3.685

8.  Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome.

Authors:  N A Graudal; M Svenson; U Tarp; P Garred; A-G Jurik; K Bendtzen
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

9.  Anti-IL-1 alpha autoantibodies in patients with rheumatic diseases and in healthy subjects.

Authors:  H Suzuki; T Ayabe; J Kamimura; H Kashiwagi
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

10.  Characterization and detection of naturally occurring antibodies against IL-1 alpha and IL-1 beta in normal human plasma.

Authors:  P Gallay; J P Mach; S Carrel
Journal:  Eur Cytokine Netw       Date:  1991 Nov-Dec       Impact factor: 2.737
View more
  3 in total

Review 1.  Selected cytokine pathways in rheumatoid arthritis.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Semin Immunopathol       Date:  2017-02-17       Impact factor: 9.623

Review 2.  IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels.

Authors:  Marie Robert; Pierre Miossec
Journal:  Front Med (Lausanne)       Date:  2019-01-14

Review 3.  Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy.

Authors:  N M Luheshi; N J Rothwell; D Brough
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.